- Primary care physicians attitudes and practice for management of osteoporosis in Inchon city
-
Lee SJ, Jang YO, Yi SH, Kawk IH, Choi JH, Yi HM
- KMID: 2295428
- J Korean Acad Fam Med.
- 1998 Jun;19(6):437-444.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study
-
Lim YL, Kim MY, Jang YO, Baik SK, Kwon SO
- KMID: 2389359
- Gut Liver.
- 2017 Sep;11(5):702-710.
- doi: 10.5009/gnl16478
BACKGROUND/AIMS: Non-selective beta blockers (NSBBs) are currently the only accepted regimen for preventing portal hypertension (PHT)-related complications. However, the effect of NSBBs is insufficient in many cases. Bacterial translocation (BT)... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis
-
Jang YO, Jun BG, Baik SK, Kim MY, Kwon SO
- KMID: 2164364
- Clin Mol Hepatol.
- 2015 Jun;21(2):141-149.
- doi: 10.3350/cmh.2015.21.2.141
BACKGROUND/AIMS: Therapies involving bone-marrow-derived mesenchymal stem cells (BM-MSCs) have considerable potential in the management of hepatic disease. BM-MSCs have been investigated in regenerative medicine due to their ability to secrete... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis
-
Lim YL, Choi E, Jang YO, Cho YZ, Kang YS, Baik SK, Kwon SO, Kim MY
- KMID: 2382351
- Gut Liver.
- 2016 Jan;10(1):109-116.
- doi: 10.5009/gnl14345
BACKGROUND/AIMS: Levels of serum apelin (s-apelin), an endogenous ligand for angiotensin-like receptor 1, have been shown to be related to hepatic fibrosis and hemodynamic abnormalities in preclinical studies. We investigated... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of Fibroblast Growth Factor 21 and β-Klotho Regulates Hepatic Fibrosis through the Nuclear Factor-κB and c-Jun N-Terminal Kinase Pathways
-
Lee KJ, Jang YO, Cha SK, Kim MY, Park KS, Eom YW, Baik SK
- KMID: 2417312
- Gut Liver.
- 2018 Jul;12(4):449-456.
- doi: 10.5009/gnl17443
BACKGROUND/AIMS: Fibroblast growth factor (FGF) 21 is associated with hepatic inflammation and fibrosis. However, little is known regarding the effects of inflammation and fibrosis on the β-Klotho and FGF21 pathway... -
- CITED
-
- Close
- SHARE
-
- Close
- Relationship between Tetrahydrobiopterin and Portal Hypertension in Patients with Chronic Liver Disease
-
Hong WK, Shim KY, Baik SK, Kim MY, Cho MY, Jang YO, Park YS, Han J, Kim G, Cho YZ, Hwang HW, Lee JH, Chae MH, Kwon SO
- KMID: 1734927
- J Korean Med Sci.
- 2014 Mar;29(3):392-399.
- doi: 10.3346/jkms.2014.29.3.392
Tetrahydrobiopterin (BH4) is an essential cofactor in NO synthesis by endothelial nitric oxide synthase (eNOS) enzymes. It has been previously suggested that reduced intrahepatic BH4 results in a decrease in... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum hyaluronic acid level: Correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model
-
Kim MY, Baik SK, Jang YO, Suk KT, Kim JW, Kim HS, Cho MY, Choi SJ, Um SH, Han KH
- KMID: 760780
- Korean J Hepatol.
- 2008 Jun;14(2):159-167.
- doi: 10.3350/kjhep.2008.14.2.159
BACKGROUNDS/AIMS: The serum level of hyaluronic acid (HA) has been suggested as a useful serologic marker for hepatic fibrosis. However, the relationship between serum HA levels and quantitative markers... -
- CITED
-
- Close
- SHARE
-
- Close
